Effect of RAG1 on the products of ligation. (A) RAG1 by itself does not influence ligation. Ring closure assays were performed in the presence of 3 nM IS95 equilibrated with increasing amounts of MBP-RAG1-D708A prior to ligation. Lanes 1 to 3, control reactions lacking various components, as indicated above the lanes; lanes 4 to 18, MBP-RAG1-D708A at 1.25, 2.5, 3.75, 5, 7.5, 10, 12.5, 15, 30, 45, 60, 90, 120, 150, and 300 nM, respectively (all lanes [4 to 18] lack HMG2). Sizes of molecular mass markers are indicated in base pairs on the left. (B) RAG1 inhibits ligation in the presence of HMG2. Ring closure assays were performed in the presence of 3 nM IS95 equilibrated with 22.5 nM HMG2 and increasing amounts of MBP-RAG1-D708A prior to ligation. Lanes 1 to 3, control reactions lacking various components, as indicated above the lanes; lanes 4 to 19, MBP-RAG1-D708A at 1.25, 2.5, 3.75, 5, 7.5, 10, 12.5, 15, 30, 45, 60, 90, 120, 150, 300, and 900 nM, respectively (all lanes [4 to 19] also contained 22.5 nM HMG2). Sizes of molecular mass markers are indicated in base pairs on the left. LM, linear monomeric 263-bp IS95 substrate; LD, linear dimers of IS95; MC, monomeric circles. The inset shows the quantitation of the data from panels A and B, represented graphically as the fraction circularization efficiency (see Materials and Methods) versus the concentration of MBP-RAG1-D708A.